Establishing Comprehensive Donor Characterization Panels to Predict Manufacturing Performance
9:00 am - Tuesday 8th December 2026
- Establishing donor pre-screening assays to characterize donor materials from a molecular, phenotypic and/or functional perspective ahead of full-scale manufacturing
- Leveraging characterization data to accelerate selection of high-performing donor materials for the manufacturing of consistent and high-quality cell therapy products
- Implementing workflows to identify starting material attributes correlating with cell therapy product manufacturability, quality and consistency to minimize manufacturing failures and lot-to-lot variability
